---
$id: https://graph.org.ai/products/commodity/51111644
$type: Product
source: UNSPSC
code: "51111644"
title: "Lonidamine"
class: "51111600"
classTitle: "Antimetabolites"
family: "51110000"
familyTitle: "Antineoplastic agents"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Lonidamine

**UNSPSC Code**: 51111644
**Class**: [Antimetabolites](Antimetabolites.mdx)
**Family**: [Antineoplastic agents](../Antineoplastic agents.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes a radiosensitizing agent and multidrug resistance modulator with the molecular formula C15H10Cl2N2O2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier U78804BIDR, chemically known as 1h-indazole-3-carboxylic acid, 1-((2,4-dichlorophenyl)methyl)- (9ci) but generally known as lonidamine, which bears US NIH Compound Identifier 39562. European Medicines Agency schedules Lonidamine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB08571MIG. The term LONIDAMINE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 32, No 10 1978, List 18). World Health Organization schedules lonidamine in its Anatomical Therapeutic Chemical (ATC) Classification. LONIDAMINE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule lonidamine under HS 29339990 and SITC 51577. As of Q4 2014, LONIDAMINE remains the US FDA Preferred Term for this commodity. Lonidamine bears US NLM identifiers UMLS ID C0065175 and NCI Concept Code C1146. SMILES: CLC1C(CN2NC(C3C2CCCC3)C(=O)O)CCC(CL)C1.

